Lili Ding Princess Margaret Cancer Center University Health Network Biography Publications Institution JoVE Articles Lili Ding has not added a biography. If you are Lili Ding and would like to personalize this page please email our Author Liaison for assistance. Publications Evaluation of Novel Imaging Devices for Nanoparticle-Mediated Fluorescence-Guided Lung Tumor Therapy The Annals of Thoracic Surgery. Jun, 2019 | Pubmed ID: 30742818 Porphyrin-High-Density Lipoprotein: A Novel Photosensitizing Nanoparticle for Lung Cancer Therapy The Annals of Thoracic Surgery. Feb, 2019 | Pubmed ID: 30316853 Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent Bioconjugate Chemistry. 11, 2018 | Pubmed ID: 30350576 Porphysome Nanoparticles for Enhanced Photothermal Therapy in a Patient-derived Orthotopic Pancreas Xenograft Cancer Model: a Pilot Study Journal of Biomedical Optics. Aug, 2016 | Pubmed ID: 27552306 A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics ACS Nano. Apr, 2015 | Pubmed ID: 25830219 Efficiente Consegna Sistemica Di SiRNA Usando Nanoparticelle Di Lipidi Del Peptide Mimando Di Lipoproteine Ad Alta Densità Nanomedicine (London, England). Dec, 2012 | Pubmed ID: 22830501 Attenuazione Di Immaturi Cella-uccidere Usando Un Peptide Che Mimano Lipoproteine Ad Alta Densità - Fosfolipide Nanoscaffold Nanomedicine (London, England). Jun, 2011 | Pubmed ID: 21718175 Un modello di cancro endometriale ortotopico con retroperitoneale Lmphadenopatia fatta da cellule VX2 in vivo propagate e coltivate Lauren Philp1,2, Harley Chan3, Marjan Rouzbahman4, Ariana Rostami5, Lili Ding6, Scott V. Bratman5,6, Margarete K. Akens5,7,8, Jonathan C. Irish7,9,11, Marcus Q. Bernardini10, Gang Zheng5,11 1Institute of Medical Science, University of Toronto, 2Department of Obstetrics and Gynecology, University of Toronto, 3Guided Therapeutics Laboratory, TECHNA Institute, University Health Network, 4Department of Pathology, Princess Margaret Cancer Center, University Health Network, 5Department of Medical Biophysics, University of Toronto, 6Princess Margaret Cancer Center, University Health Network, 7Techna Institute, University Health Network, 8Department of Surgery, University of Toronto, 9Department of Otolaryngology, Head and Neck Surgery, University of Toronto, 10Division of Gynecologic Oncology, University of Toronto /Princess Margaret Cancer Center, University Health Network, 11Princess Margaret Cancer Center, University Health Network JoVE 59340 Cancer Research
Un modello di cancro endometriale ortotopico con retroperitoneale Lmphadenopatia fatta da cellule VX2 in vivo propagate e coltivate Lauren Philp1,2, Harley Chan3, Marjan Rouzbahman4, Ariana Rostami5, Lili Ding6, Scott V. Bratman5,6, Margarete K. Akens5,7,8, Jonathan C. Irish7,9,11, Marcus Q. Bernardini10, Gang Zheng5,11 1Institute of Medical Science, University of Toronto, 2Department of Obstetrics and Gynecology, University of Toronto, 3Guided Therapeutics Laboratory, TECHNA Institute, University Health Network, 4Department of Pathology, Princess Margaret Cancer Center, University Health Network, 5Department of Medical Biophysics, University of Toronto, 6Princess Margaret Cancer Center, University Health Network, 7Techna Institute, University Health Network, 8Department of Surgery, University of Toronto, 9Department of Otolaryngology, Head and Neck Surgery, University of Toronto, 10Division of Gynecologic Oncology, University of Toronto /Princess Margaret Cancer Center, University Health Network, 11Princess Margaret Cancer Center, University Health Network JoVE 59340 Cancer Research